Ameriprise’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $824K | Sell |
142,148
-1,315
| -0.9% | -$8.72K | ﹤0.01% | 3387 |
|
|
2025
Q4 | $1.13M | Sell |
143,463
-10,705
| -7% | -$84.3K | ﹤0.01% | 3280 |
|
|
2025
Q3 | $1.25M | Buy |
154,168
+5,140
| +3% | +$34.1K | ﹤0.01% | 3243 |
|
|
2025
Q2 | $696K | Sell |
149,028
-19,074
| -11% | -$87.4K | ﹤0.01% | 3408 |
|
|
2025
Q1 | $923K | Sell |
168,102
-41,821
| -20% | -$169K | ﹤0.01% | 3242 |
|
|
2024
Q4 | $712K | Sell |
209,923
-7,166
| -3% | -$23.1K | ﹤0.01% | 3395 |
|
|
2024
Q3 | $619K | Sell |
217,089
-2,817
| -1% | -$7.24K | ﹤0.01% | 3413 |
|
|
2024
Q2 | $495K | Sell |
219,906
-733,330
| -77% | -$1.48M | ﹤0.01% | 3413 |
|
|
2024
Q1 | $2.11M | Buy |
953,236
+433,115
| +83% | +$1.12M | ﹤0.01% | 2844 |
|
|
2023
Q4 | $1.22M | Sell |
520,121
-67,817
| -12% | -$125K | ﹤0.01% | 3110 |
|
|
2023
Q3 | $1.09M | Sell |
587,938
-4,570
| -0.8% | -$10.5K | ﹤0.01% | 3099 |
|
|
2023
Q2 | $1.55M | Buy |
592,508
+23,261
| +4% | +$59.2K | ﹤0.01% | 2992 |
|
|
2023
Q1 | $928K | Sell |
569,247
-820
| -0.1% | -$1.03K | ﹤0.01% | 3187 |
|
|
2022
Q4 | $758K | Hold |
570,067
| – | – | ﹤0.01% | 3253 |
|
|
2022
Q3 | $890K | Buy |
570,067
+156,573
| +38% | +$259K | ﹤0.01% | 3170 |
|
|
2022
Q2 | $638K | Sell |
413,494
-4,270
| -1% | -$9.01K | ﹤0.01% | 3310 |
|
|
2022
Q1 | $1.07M | Buy |
417,764
+367,163
| +726% | +$897K | ﹤0.01% | 3188 |
|
|
2021
Q4 | $168K | Buy |
50,601
+2,401
| +5% | +$5.19K | ﹤0.01% | 3811 |
|
|
2021
Q3 | $118K | Sell |
48,200
-400
| -0.8% | -$1.16K | ﹤0.01% | 3768 |
|
|
2021
Q2 | $198K | Buy |
48,600
+4,905
| +11% | +$18.7K | ﹤0.01% | 3757 |
|
|
2021
Q1 | $197K | Buy |
43,695
+33,680
| +336% | +$182K | ﹤0.01% | 3709 |
|
|
2020
Q4 | $49K | Sell |
10,015
-7,095
| -41% | -$35.5K | ﹤0.01% | 3725 |
|
|
2020
Q3 | $101K | Buy |
+17,110
| New | +$68.4K | ﹤0.01% | 3639 |
|
Other funds holding XERS
VCM
RA
N
VPM
